Preparation of paclitaxel liposomes modified with mPEG-DSPE and its pharmacokinetics in rats

Chinese Pharmaceutical Journal

Volumn 43, Issue 3, 2008, Pages 199-202

  Zhang, Zi Qiang ^a,b   Qin, Bin ^a   Li, Zhan ^a,b   Yao, Jing ^b  

^a China Pharmaceutical University   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Liposome; MPEG DSPE; Paclitaxel; Pharmacokinetics

Indexed keywords

DISTEAROYL PHOSPHATIDYLETHANOLAMINE; LIPOSOME; MACROGOL; MACROGOL 2000; PACLITAXEL; PHOSPHATIDYLETHANOLAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; ENCAPSULATION; FILM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; LIPID MEMBRANE; NONHUMAN; PARTICLE SIZE; RAT; SYNTHESIS; TECHNIQUE;

EID: 52749091815     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. MEI L, SUN H F, SONG C X. Advances in paclitaxel liposome[J]. China Pharm J,2006,41(18):1366-1370.
2. FJALLSKOG M L, FRJJ L, BERGH J. Is cremophor EL solvent for paclitaxel, cytotoxic?[J]. Lancet,1993,342(8875):873.
3. ZHANG J Q, ZHANG Z R, QIN S R. Study on long circulating magnetoliposome entrapped paclitaxel[J]. China Pharm J,2003,38(7):520-522.
4. SUN P, DENG S H, YU W P. Preparation of long circulation allitridin PEG-Liposomes and its pharmacokinetics[J]. Prad J Cardiac Cereb Pneum Vase Dis,2006,14(6):454-456.
5. ZHANG X J, ZHANG P. Advances in clinical research and development of new form of paclitaxel[J]. Oncol Prog,2007,5(1):66-72.
6. YANASE M, SHINKAI M, HONDA H, et al. Antitumor immunity induction by intracellular hyperthermia using magnetite cationic liposome[J]. Jpn J Cancer Res,1998,89(7):775-782.
7. CAMPBELL R B, BALASUBRAMANIAN S V, STRAUBINGER R M. Influence of cationic lipids on the stability and membrane properties of paclitaxel containing liposomes[J]. J Pharm Sci,2001,90(8):1091-1105.
8. MIRON T, WILCHEK M. A simplified method for the preparation of succinimidyl carbonate polyethylene glycol for coupling to proteins[J]. Bioconjug Chem,1993,4(6):568-569.
9. ALEXANDER L K, KAZUO M, VLADIMIR P T. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes[J]. FEBS Lett,1990,268(1):235-237.
10. SHARMA A, CONWAY W D, STRAUBINGER R M. Reversed-phase high- performance liquid chromatographic determination of taxol in mouse plasma[J]. J Chromatogr B Biomed Appl,1994,655(2):315-319.
11. MARTIN N, CATALIN J, BLACHON M F, et al. Assay of paclitaxel (taxol) in plasma and urine by high-performance liquid chromatography[J]. J Chromatogr B Biomed Sci Appl,1998,709(2):281-288.
12. AWASTHI V D, GARCIA D, GOINS B A, et al. Circulation and biodistribution profiles of long-circulating PEG-liposomes of various sizes in rabbits[J]. Int J Pharm,2003(1-2):121-132.
13. ZHOU W, LU Q, WENG G Y. Pharmacokinetics of taxol-liposome in rat[J]. J Chin Pharm Univ,2000,31(6):443-446.
14. CROSASSO P, CERUTI M, BRUSA P, et al. Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes[J]. J Controlled Release ,2000,63(1-2):19-30.